Palvella Therapeutics, Inc. (PVLA) /
The profitability of Palvella Therapeutics, Inc. over the past 10 years
Chart Palvella Therapeutics, Inc.: operating income, net income, fiscal 2016–2025 Open the chart →Palvella Therapeutics, Inc. reported a net loss of $41.72M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $38.6M. It reported a profit in 1 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2024 and 2025. Its highest net income in these years was $18.69M, in fiscal 2023.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$38.6M | -$41.72M |
| 2024ended Dec 31, 2024 | -$14.1M | -$17.43M |
| 2023ended Dec 31, 2023 | -$11.87M | $18.69M |
| 2022ended Dec 31, 2022 | -$43.47M | -$33.28M |
| 2021ended Dec 31, 2021 | -$51.83M | -$45.74M |
| 2020ended Dec 31, 2020 | -$33.92M | -$37.23M |
| 2019ended Dec 31, 2019 | -$27.16M | -$25.47M |
| 2018ended Dec 31, 2018 | -$30.83M | -$26.75M |
| 2017ended Dec 31, 2017 | -$14.59M | -$17.65M |
| 2016ended Dec 31, 2016 | -$22.76M | -$22.8M |
Fiscal years as Palvella Therapeutics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Palvella Therapeutics, Inc.
- The revenue of Palvella Therapeutics, Inc.
- The cash flow of Palvella Therapeutics, Inc.
- The debt of Palvella Therapeutics, Inc.
- All of Palvella Therapeutics, Inc.'s financials, charted
Companies of a similar size
- NEOGNeogen Corporation
- PHINPHINIA INC.
- BBTBeacon Financial Corp
- WLYJOHN WILEY & SONS, INC.
- FCPTFour Corners Property Trust, Inc.
Not investment advice. This page shows what Palvella Therapeutics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.